Actavis Inc. and Warner Chilcott plc have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion.

Crushing, fracturing, and bending tests quantify hardness.

Program aims to develop a novel oral treatment.

Elan will purchase interest in four respiratory programs.

Thomson Reuters released a report that provides a view of the challenges facing companies entering the United States biosimilar drug market.

FDA has released guidance on best practices for conducting and reporting pharmacoepidemiologic safety studies.

Biotage issued a statement in response to a recent announcement from CEM Corporation about a patent issue with Biotage.

New Center for Pharmaceutical Advancement and Training increases number of experts and available tools in Sub-Saharan countries.

Eli Lilly reported that enzastaurin did not meet the primary endpoint in a Phase III study, which evaluated the agent as a monotherapy for the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL).

Takeda and US vaccines maker Inviragen jointly announced that they have entered into a definitive agreement for Takeda to acquire Inviragen for an upfront payment of US$35 million and future payments of up to US$215 million upon achievement of key commercial milestones, linked to the progress of clinical development.

In its commitment to transparency, GlaxoSmithKline (GSK) has outlined plans to share detailed data from its clinical trials. GSK is to establish a new online system that will enable researchers to request access to anonymised patient level data.

CEM Corp. announced that its European Patent covering microwave assisted solid phase peptide synthesis has been upheld.

The workshop will cover a proposed new method for measuring moisture vapor transmission rate.

New line in Swiss facility produces ready-to-fill syringes.

EMA streamlines orphan drug application procedure.

New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.

Pfizer has launched a prescription-fulfillment website for Viagra tablets in an effort to combat the online sale of counterfeited medicine.

The Global Vaccine Action plan maps out a strategy to increase access and R&D for vaccines.

More than 12,000 industry professionals, including 8,100 show attendees, participated in INTERPHEX 2013, a 20% increase over the 2012 show.

While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Drug companies team up with INTERPOL to keep counterfeit medicines off the Internet and out of the hands of patients.

FDA faces budget crunch; Supreme Court hears key cases

Loss-in-weight feeders provide high accuracy for batch or continuous processes.

Wanted: Article contributions on drug and process development topics.

Genentech announced that FDA has approved Actemra (tocilizumab) for the treatment of polyarticular juvenile idiopathic arthritis (PJIA) in children aged two years and older.

Pharmaco-Kinesis Corporation (PKC) announced that it is developing the first nanodrug combination of Merck's temozolomide and Celgene's thalidomide (in a 50:50 ratio) for the treatment of gliomas and other cancers. PKC will collaborate with the University of California, San Diego's department of nano-engineering at the Moores cancer centre to develop the nanodroplet formulation.

Bayer announced that it has signed a merger agreement with US-based birth-control specialist Conceptus.